A 70-year-old with HFrEF (EF 25%) on ARNI, beta-blocker, MRA, SGLT2i remains NYHA III. Which therapy may reduce HF hospitalization in high-risk patien...

Question

A 70-year-old with HFrEF (EF 25%) on ARNI, beta-blocker, MRA, SGLT2i remains NYHA III. Which therapy may reduce HF hospitalization in high-risk patients recently decompensated?

Accepted Answer

Vericiguat

Answer

NSAID

Answer

DPP-4 inhibitor

Answer

SGLT2i remains NYHA III. Which therapy may reduce HF hospitalization in high-risk patients recently decompensated?

Answer

Ivabradine with HR 60/min

"cardiology" MCQ (SBA): Heart Failure

A 70-year-old with HFrEF (EF 25%) on ARNI, beta-blocker, MRA, SGLT2i remains NYHA III. Which therapy may reduce HF hospitalization in high-risk patients recently decompensated?